Cargando…
Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France
BACKGROUND: We aimed to describe the frequency, risk factors, and costs attributable to drug–drug interactions (DDIs) among an aging French HIV population. METHODS: We conducted a retrospective cohort study using French nationwide health care e-records: the SNIIRAM database. People living with HIV (...
Autores principales: | Demessine, Ludivine, Peyro-Saint-Paul, Laure, Gardner, Edward M, Ghosn, Jade, Parienti, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440683/ https://www.ncbi.nlm.nih.gov/pubmed/30949521 http://dx.doi.org/10.1093/ofid/ofz051 |
Ejemplares similares
-
Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020) -
Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial
por: Defer, Gilles, et al.
Publicado: (2018) -
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016) -
Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication
por: Parienti, Jean-Jacques, et al.
Publicado: (2021) -
Drug Resistance in HIV-Positive Adults During the Initial Year of
Antiretroviral Treatment at Ethiopian Health Centers
por: Reepalu, Anton, et al.
Publicado: (2021)